Compare Procter & Gamble Health with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs PIRAMAL ENTERPRISES - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PROCTER & GAMBLE HEALTH PIRAMAL ENTERPRISES PROCTER & GAMBLE HEALTH/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 40.7 8.4 483.1% View Chart
P/BV x 4.2 0.6 724.5% View Chart
Dividend Yield % 11.3 3.1 369.2%  

Financials

 PROCTER & GAMBLE HEALTH   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
PIRAMAL ENTERPRISES
Mar-19
PROCTER & GAMBLE HEALTH/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3,5493,303 107.5%   
Low Rs1,3011,797 72.4%   
Sales per share (Unadj.) Rs511.4716.5 71.4%  
Earnings per share (Unadj.) Rs61.379.7 76.9%  
Cash flow per share (Unadj.) Rs74.0107.9 68.6%  
Dividends per share (Unadj.) Rs440.0028.00 1,571.4%  
Dividend yield (eoy) %18.11.1 1,652.1%  
Book value per share (Unadj.) Rs927.81,477.5 62.8%  
Shares outstanding (eoy) m16.60184.45 9.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x4.73.6 133.2%   
Avg P/E ratio x39.632.0 123.7%  
P/CF ratio (eoy) x32.823.6 138.7%  
Price / Book Value ratio x2.61.7 151.5%  
Dividend payout %717.935.1 2,043.5%   
Avg Mkt Cap Rs m40,257470,292 8.6%   
No. of employees `0001.17.8 14.5%   
Total wages/salary Rs m1,31322,504 5.8%   
Avg. sales/employee Rs Th7,486.716,899.4 44.3%   
Avg. wages/employee Rs Th1,157.62,877.7 40.2%   
Avg. net profit/employee Rs Th897.21,879.9 47.7%   
INCOME DATA
Net Sales Rs m8,490132,153 6.4%  
Other income Rs m2443,128 7.8%   
Total revenues Rs m8,734135,281 6.5%   
Gross profit Rs m1,48266,290 2.2%  
Depreciation Rs m2115,202 4.1%   
Interest Rs m044,097 0.0%   
Profit before tax Rs m1,51420,119 7.5%   
Minority Interest Rs m03,194 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m5638,611 6.5%   
Profit after tax Rs m1,01714,701 6.9%  
Gross profit margin %17.550.2 34.8%  
Effective tax rate %37.142.8 86.8%   
Net profit margin %12.011.1 107.7%  
BALANCE SHEET DATA
Current assets Rs m15,343122,742 12.5%   
Current liabilities Rs m1,960310,810 0.6%   
Net working cap to sales %157.6-142.3 -110.8%  
Current ratio x7.80.4 1,982.0%  
Inventory Days Days4923 211.3%  
Debtors Days Days2839 73.2%  
Net fixed assets Rs m1,209116,904 1.0%   
Share capital Rs m166369 45.0%   
"Free" reserves Rs m15,235272,161 5.6%   
Net worth Rs m15,401272,530 5.7%   
Long term debt Rs m0270,196 0.0%   
Total assets Rs m17,595856,261 2.1%  
Interest coverage xNM1.5-  
Debt to equity ratio x01.0 0.0%  
Sales to assets ratio x0.50.2 312.6%   
Return on assets %5.86.9 84.2%  
Return on equity %6.65.4 122.5%  
Return on capital %10.312.4 82.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,63615,200 10.8%   
Fx outflow Rs m4,3684,889 89.3%   
Net fx Rs m-2,73210,312 -26.5%   
CASH FLOW
From Operations Rs m-1,304-115,975 1.1%  
From Investments Rs m12,697-8,265 -153.6%  
From Financial Activity Rs m-301107,525 -0.3%  
Net Cashflow Rs m11,093-16,650 -66.6%  

Share Holding

Indian Promoters % 0.0 52.9 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 4.0 455.0%  
FIIs % 1.0 26.6 3.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 16.5 176.4%  
Shareholders   28,591 93,274 30.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PROCTER & GAMBLE HEALTH With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT  ABBOTT INDIA  FRESENIUS KABI ONCO.  

Compare PROCTER & GAMBLE HEALTH With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 500 Points; Kotak Mahindra Bank & IndusInd Bank Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note, as investors worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (2QFY20); Net Profit Down 13.0% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 358 m (down 13.0% YoY). Sales on the other hand came in at Rs 2 bn (down 0.4% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY20); Net Profit Up 16.5% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 16.5% YoY). Sales on the other hand came in at Rs 36 bn (up 14.6% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout...(The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Apr 3, 2020 03:35 PM

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - ALEMBIC LTD COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS